Here we show that the prostate tumor suppressor PGC1α exerts a paracrine growth-inhibitory effect on cancer cells, through the regulation of the secretome composition, and this phenotype is dependent on its transcriptional partner ERRα and restricted to the protein soluble fraction of the secretome. The gene discussed is PPARGC1A; the disease is prostate neoplasm.